Protagenic Therapeutics, Inc. (PTIX)

OTCMKTS · Delayed Price · Currency is USD

0.7500

-0.0500 (-6.25%)

At close: Oct 15, 2026

Protagenic Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025
Period Ending	Oct '26 Oct 14, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
Market Capitalization	1	1	-
Market Cap Growth	-76.60%	-	-
Enterprise Value	1	3	-
Last Close Price	0.75	0.68	-

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025
Period Ending	Oct '26 Oct 14, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
PE Ratio	0.25	0.90	-
PB Ratio	0.79	0.47	-
P/TBV Ratio	0.79	0.47	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025
Period Ending	Oct '26 Oct 14, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
Debt / Equity Ratio	-	-	-0.49
Net Debt / Equity Ratio	-0.33	-0.58	-0.49
Net Debt / EBITDA Ratio	0.13	0.34	-
Net Debt / FCF Ratio	0.28	0.54	-1.38
Quick Ratio	0.53	1.46	0.02
Current Ratio	0.66	1.50	0.02
Return on Assets (ROA)	-57.31%	-150.55%	-
Return on Capital Employed (ROCE)	-247.00%	-172.00%	52.40%

Yields

Fiscal Year	Current	FY 2026	FY 2025
Period Ending	Oct '26 Oct 14, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025
Earnings Yield	402.30%	111.54%	-
FCF Yield	-147.55%	-229.13%	-
Buyback Yield / Dilution	62.49%	56.65%	-